Indonesian Political, Business & Finance News

BRIN Accelerates Development of Infection Drugs Based on Indonesian Resources

| Source: Antara (Indonesian) Translated from Indonesian | Health
BRIN Accelerates Development of Infection Drugs Based on Indonesian Resources
Image: Antara (Indonesian)

Jakarta (ANTARA) - The National Research and Innovation Agency (BRIN) is accelerating the development of drug candidates for infectious diseases based on Indonesia’s biological wealth as a strategic step to strengthen national pharmaceutical resilience.

The effort was carried out through the International Symposium on Drug Discovery and Development in Jakarta on Tuesday, which brought together researchers from Indonesia, Japan and Malaysia to strengthen the scientific foundations of infectious disease drug development, from the discovery of lead compounds to preclinical safety testing.

“Indonesia is a megabiodiverse country with enormous potential to discover new therapeutic compounds from its biological resources. However, translating that potential into viable drug candidates remains a challenge that must be accelerated through research and development,” said BRIN Deputy Chairman Amarulla Octavian in a written statement.

He noted that infectious diseases remain a major global health challenge. Indonesia itself still faces various endemic diseases such as malaria, tuberculosis, dengue fever and amoebiasis, which are becoming increasingly complex due to climate change, globalisation and rising pathogen resistance.

Amarulla said strengthening research capacity is also an important part of supporting national pharmaceutical resilience, in line with the government’s strategic priorities. Indonesia currently imports more than 90 per cent of the raw materials and active pharmaceutical ingredients used by the national pharmaceutical industry.

According to him, this situation drives BRIN to continue optimising the use of Indonesia’s biodiversity as a source of health innovation.

“BRIN is committed to reducing this dependency by making more optimal use of Indonesia’s biodiversity through the development of health technologies and innovations that can boost national competitiveness while addressing public health challenges,” he said.

Amarulla emphasised that drug development is a complex process that cannot be carried out by a single institution alone.

Cross-disciplinary collaboration is needed to bridge all stages of research, from compound discovery and lead optimisation to in vivo efficacy testing and preclinical safety evaluation.

“The research we carry out must be able to bridge the valley of death through translational research, lead optimisation, and comprehensive preclinical safety and efficacy evaluations,” he said.

“We need to translate local biodiversity and early-stage research results into viable therapeutic candidates for endemic infectious diseases, so as to deliver real impact on national health resilience and contribute to addressing global health crises,” Amarulla Octavian said.

He assessed that the growing threat of drug resistance makes the development of new drugs increasingly urgent.

“Drug discovery cannot be achieved by a single researcher or a single institution. Close cross-disciplinary collaboration and knowledge-sharing partnerships are required. We hope this symposium can strengthen research networks, particularly for young researchers, and give rise to new collaborations that support the development of life-saving drugs,” said Hiroyuki Matsuda.

More from 4 August 2026 →

Cite this article
Source: jawawa.id (https://jawawa.id/newsitem/brin-accelerates-development-of-infection-drugs-based-on-indonesian-resources-1785851702)
Originally published by Antara (Indonesian) (https://www.antaranews.com/berita/5679717/brin-percepat-pengembangan-obat-infeksi-berbasis-sumber-daya-indonesia), translated from Indonesian
Print